Refine by
Metastasis Suppliers & Manufacturers
43 companies found
based in, NETHERLANDS
At veriNOS Pharmaceuticals, we focus on the clinical development of a drug that specifically inhibits a defined cascade that is relevant and common in different disease settings. The activation of iNOS with subsequent excessive production of cell ...
Ronopterin – treatment to reduce peritumoral brain edema and improve patient outcomes. Adequate pharmacologic control of peritumoral edema in glioblastoma and brain metastases is still insufficient and is limited by side effects in more than ...
based inLlanera, SPAIN
A 100% Spanish owned biotechnological company specialising in the design, development and manufacture of nano-systems for drug delivery applications. Our technology is focussed on applications in the field of medicine where we develop systems to ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
INOVIQ has developed a proprietary immunocytochemistry (ICC) assay that detects hTERT, a component of telomerase, which is upregulated in most human epithelial ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Chlorpromazine hydrochloride exerts anti-cancer activity through a variety of pathways, including anti-proliferation, induction of autophagy and cycle arrest (G2-M phase), inhibition of cytochrome c oxidase (CcO), inhibition of tumour growth and ...
based inLakewood, NEW JERSEY (USA)
We are an ISO9001 Certified manufacturer of enzymes and biochemicals for life science research, primary and stem cell isolation, bioprocessing, biopharma, diagnostics and biotechnology applications. Backed by over 75 years of expertise, we maintain ...
Prepared by modification of the procedure of Spudich and Watt, J. Biol. Chem., 246, 4866 (1971). Purity checked by SDS-PAGE. A lyophilized powder. Store at ...
based inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
based inTampa, FLORIDA (USA)
Inspirata, Inc. helps patients fighting cancer, and the clinicians they trust, make every moment matter. Our comprehensive cancer informatics solutions bring together disparate data throughout the entire cancer care journey to drive informed ...
based in, CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
based inFriendswood, TEXAS (USA)
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...
Castle Biosciences offers DecisionDx-PRAME gene expression profile testing to assess expression of the PRAME (preferentially expressed antigen in melanoma) gene. DecisionDx-PRAME is an optional, additional test that can be run on the same sample as ...
based inSan Diego, CALIFORNIA (USA)
In our last venture, our Executive Chairman and CEO, both board certified physicians, led a team of talented and dedicated engineers to invent MediTouch, the first cloud-based EHR with touch technology on the iPad. It simplified the way providers ...
based inGuro-gu, SOUTH KOREA
We provide diagnostic solutions throughout the cancer treatment cycle from early cancer diagnosis to prognostic and companion diagnostics as well as postoperative monitoring. Diagnose cancer as early as possible, when the disease is easiest to ...
CTCs(Circulating Tumor Cells) are cancer cells found in blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. Geno ...
based inTehran, IRAN
Pars Isotope Co is a prominent supplier and producer of radioisotopes in Iran, catering widely to the medical and industrial sectors. As the sole provider in the region, the company focuses on radiopharmaceuticals used for both the diagnosis and ...
The binding of this radiopharmaceutical to PSMA receptors enables effective delivery of radionuclide therapy directly to both the primary cancer cells and its metastasis. This approach aims to reduce tumor sizes and cancer cell ...
based inAnyang-si, SOUTH KOREA
Vieworks leads the innovation of imaging technologies together with talented individuals who are passionate, creative, and ethical. The company name, Vieworks, combined the words “View” and “Works,” which represents the company’s will to contribute ...
based inWashington, DISTRICT OF COLUMBIA (USA)
TriStar is a Maryland LLC founded in 2003 with a business office in Washington DC. Our manufacturing, IHC and Molecular Lab is in Catania (Italy) and collaborating Medical institutes in Germany, Italy, UK & France TriStar has pioneered the use of ...
based inBaldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
based inCarlsbad, CALIFORNIA (USA)
Qualigen is a biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack diagnostic platform. The FastPack line of FDA-cleared and ...
based inMenlo Park, CALIFORNIA (USA)
Ionpath, Inc., is a pioneer in high-definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate medical discovery and improve human health. Ionpath’s MIBI (multiplexed ion beam imaging) platform breaks through the ...
![Ionpath - Model 164Dy - a-SMA [D4K9N] Antibody](https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzExOTg1Mi9wcm9kdWN0cy83OTY1NTkvMTE5ODUyXzJfMjAyMjA3MTYwNjUwNTU1MDE3NTc1X3Jhdy5wbmciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MTQzLCJoZWlnaHQiOjEwMn19fQ== "Ionpath - Model 164Dy - a-SMA [D4K9N] Antibody")
Background:α-smooth muscle actin (α-SMA, ACTA2) is one of six actin isoforms found in vertebrates. α-SMA is expressed in a variety of tissues and is used as a marker of vascular smooth muscle, myofibroblasts, and cancer-associated ...
based inMunich, GERMANY
Isarna Therapeutics was built on profound knowledge in antisense oligonucleotide design and therapeutic development of this innovative compound class. Today, Isarna is developing a portfolio of antisense therapies targeting an emerging therapeutic ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
As a result, tumor tissues almost always contain a large number of endothelial cells, fibroblasts, and infiltrating inflammatory cells, which in turn produce various cytokines. Tumor-derived VEGF acts on endothelial cells, promoting angiogenesis and ...